4,4-dicarboxy-5-pyridoxylproline has been researched along with eticlopride in 1 studies
Studies (4,4-dicarboxy-5-pyridoxylproline) | Trials (4,4-dicarboxy-5-pyridoxylproline) | Recent Studies (post-2010) (4,4-dicarboxy-5-pyridoxylproline) | Studies (eticlopride) | Trials (eticlopride) | Recent Studies (post-2010) (eticlopride) |
---|---|---|---|---|---|
9 | 0 | 4 | 378 | 1 | 95 |
Protein | Taxonomy | 4,4-dicarboxy-5-pyridoxylproline (IC50) | eticlopride (IC50) |
---|---|---|---|
D(2) dopamine receptor | Mus musculus (house mouse) | 0.0009 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0009 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banala, AK; Beuming, T; Cao, J; Donthamsetti, P; Javitch, JA; LaBounty, A; Levy, B; Luedtke, RR; Michino, M; Newman, AH; Pongetti, K; Shi, L | 1 |
1 other study(ies) available for 4,4-dicarboxy-5-pyridoxylproline and eticlopride
Article | Year |
---|---|
Molecular determinants of selectivity and efficacy at the dopamine D3 receptor.
Topics: Computer Simulation; HEK293 Cells; Humans; Molecular Conformation; Molecular Dynamics Simulation; Piperazines; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D3; Static Electricity; Structure-Activity Relationship | 2012 |